{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:01:47Z","timestamp":1793314907229,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Patients with antiphospholipid syndrome (APS) have immune cell abnormalities that remain poorly understood. This study compared primary APS (PAPS) and secondary APS (SAPS) patients with healthy controls with respect to peripheral blood lymphocytes, CD4+T cell subsets, and cytokine levels. The correlation between antiphospholipid antibody titres and T helper 17 (Th17) and T regulatory (Treg) cell subsets was also analyzed, together with the correlations between cytokine profiles and the clinical characteristics of APS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The retrospective study population consisted of 67 APS patients (12 with PAPS, 55 with SAPS) and 40 healthy controls. Absolute numbers of peripheral blood lymphocyte subsets and CD4+ T cell subsets were detected by flow cytometry, and serum cytokine levels by flow cytometry bead array.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with SAPS had lower absolute values of T, B and CD4+T cells than the healthy control group, while only natural killer (NK) cell levels were decreased in patients with PAPS. Absolute numbers of T, B, NK, and CD4+T cells were significantly higher in the PAPS than SAPS group. The trends in CD4+T cell subsets were the same in PAPS and SAPS patients as in healthy controls, with increased Th1, decreased Th2, and decreased Treg levels, and thus an increased Th17\/Treg ratio. Th2, Th17, and Treg cell counts were higher in the PAPS than SAPS group. Cytokine analysis showed that only IL-10 levels differed between the two APS groups. However, the levels of all of the studied cytokines were higher in APS patients than healthy controls, and correlated with the clinical characteristics of the patients. In the PAPS group, the titres of two autoantibodies correlated positively with the Th17\/Treg ratio and negatively with the levels of D-dimer and Treg subsets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study clearly showed that APS patients have immune disturbances, the most prominent of which is an increase in the Th17\/Treg ratio, due to a decrease in the number of Treg cells. These abnormalities may be involved in the occurrence and progression of APS. An additional finding was a higher level of peripheral blood lymphocytes in PAPS than SAPS patients, which may be related to the immunosuppressive treatment of SAPS patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.873644","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T07:59:02Z","timestamp":1651823942000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Huanhuan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101463","article-title":"Antiphospholipid Syndrome","volume":"34","author":"Sammaritano","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320933009","article-title":"Long-Term Follow-Up of Antiphospholipid Syndrome: Real-Life Experience From a Single Center","volume":"29","author":"Serrano","year":"2020","journal-title":"Lupus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11926-021-01051-5","article-title":"An Update on Antiphospholipid Syndrome","volume":"23","author":"Xourgia","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of Immunothrombosis and Vasculopathy in Antiphospholipid Syndrome","author":"Knight","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of Antiphospholipid Syndrome in the General Population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(17)30066-x","article-title":"Antiphospholipid Syndrome","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci12010091","article-title":"Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review","volume":"12","author":"Man","year":"2022","journal-title":"Brain Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21090","article-title":"Obstetric Antiphospholipid Syndrome From the Perspective of a Rheumatologist","volume":"14","author":"Santacruz","year":"2022","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew054","article-title":"Oxidative Stress in the Pathogenesis of Atherothrombosis Associated With Anti-Phospholipid Syndrome and Systemic Lupus Erythematosus: New Therapeutic Approaches","volume":"55","author":"L\u00f3pez-Pedrera","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.40136","article-title":"Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12016-016-8568-1","article-title":"Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up","volume":"53","author":"Simonin","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081079","article-title":"Quantitative Abnormalities of Peripheral Blood Distinct T, B, and Natural Killer Cell Subsets and Clinical Findings in Obstetric Antiphospholipid Syndrome","volume":"36","author":"Carbone","year":"2009","journal-title":"J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","article-title":"Metabolic Modeling of Single Th17 Cells Reveals Regulators of Autoimmunity","volume":"184","author":"Wagner","year":"2021","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12026-021-09211-6","article-title":"Recent Advances in the Role of Th17\/Treg Cells in Tumor Immunity and Tumor Therapy","volume":"69","author":"Qianmei","year":"2021","journal-title":"Immunol Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05602-0","article-title":"High Serum IgA and Activated Th17 and Treg Predict the Efficacy of Abatacept in Patients With Early, Seropositive Rheumatoid Arthritis","volume":"40","author":"Inamo","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19030730","article-title":"The Balance of Th17 Versus Treg Cells in Autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1719720","DOI":"10.1155\/2016\/1719720","article-title":"The Role of TLR4 on B Cell Activation and Anti-\u03b2(2)GPI Antibody Production in the Antiphospholipid Syndrome","volume":"2016","author":"Cheng","year":"2016","journal-title":"J Immunol Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.molimm.2016.01.012","article-title":"The Effect of Toll-Like Receptor 4 on \u03b22-Glycoprotein I-Induced B Cell Activation in Mouse Model","volume":"71","author":"Cheng","year":"2016","journal-title":"Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00733-8","article-title":"The Pathogenicity of Th17 Cells in Autoimmune Diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.01.005","article-title":"Th17 Cells: From Gut Homeostasis to CNS Pathogenesis","volume":"43","author":"Buckner","year":"2022","journal-title":"Trends Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg Cells in Autoimmunity: From Identification to Treg-Based Therapies","volume":"41","author":"G\u00f6schl","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2021.11.007","article-title":"Emerging Strategies for Treating Autoimmune Disorders With Genetically Modified Treg Cells","volume":"149","author":"Boardman","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.01.038","article-title":"Increased Circulating CD4(+)CXCR5(+)FoxP3(+) Follicular Regulatory T Cells Correlated With Severity of Systemic Lupus Erythematosus Patients","volume":"56","author":"Liu","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.40430","article-title":"Increased Circulating Follicular Treg Cells Are Associated With Lower Levels of Autoantibodies in Patients With Rheumatoid Arthritis in Stable Remission","volume":"70","author":"Liu","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/jcm11020400","article-title":"The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis","volume":"11","author":"Ka\u0142u\u017cna","year":"2022","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8813558","DOI":"10.1155\/2020\/8813558","article-title":"The Function and Role of the Th17\/Treg Cell Balance in Inflammatory Bowel Disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J Immunol Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00391","article-title":"Altered Th17\/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus But Not Primary Antiphospholipid Syndrome","volume":"10","author":"\u00c1lvarez-Rodr\u00edguez","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.03.002","article-title":"Increased Activity of Interleukin-23\/Interleukin-17 Cytokine Axis in Primary Antiphospholipid Syndrome","volume":"218","author":"Popovic-Kuzmanovic","year":"2013","journal-title":"Immunobiology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315618267","article-title":"Musial J.Signs of Impaired Immunoregulation and Enhanced Effector T-Cell Responses in the Primary Antiphospholipid Syndrome","volume":"25","author":"Jakiela","year":"2016","journal-title":"Lupus"},{"key":"B30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9857-y","article-title":"Decreased Levels of Circulating CD4+CD25+Foxp3+ Regulatory T Cells in Patients With Primary Antiphospholipid Syndrome","volume":"33","author":"Dal Ben","year":"2013","journal-title":"J Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbr.2013.09.001","article-title":"Patients With Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome Have Decreased Numbers of Circulating CD4+CD25+Foxp3+ Treg and CD3\u2212CD19+ B Cells","volume":"54","author":"Dal Ben","year":"2014","journal-title":"Rev Bras Reumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19020589","article-title":"Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome","volume":"19","author":"Alvarez-Rodriguez","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines9020132","article-title":"Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It","volume":"9","author":"Mormile","year":"2021","journal-title":"Biomedicines"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.06.019","article-title":"The Antiphospholipid Syndrome as a Model for B Cell-Induced Autoimmune Diseases","volume":"114","author":"Youinou","year":"2004","journal-title":"Thromb Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.737334","article-title":"SPRC Suppresses Experimental Periodontitis by Modulating Th17\/Treg Imbalance","volume":"9","author":"Peng","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156","article-title":"The Role of Interleukin-2 During Homeostasis and Activation of the Immune System","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nri3823","article-title":"The Promise of Low-Dose Interleukin-2 Therapy for Autoimmune and Inflammatory Diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting IL-2: Biology and Therapeutic Prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","article-title":"Stem-Like Intestinal Th17 Cells Give Rise to Pathogenic Effector T Cells During Autoimmunity","volume":"184","author":"Schnell","year":"2021","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-Producing CD4+ Effector T Cells Develop via a Lineage Distinct From the T Helper Type 1 and 2 Lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/eji.201948131","article-title":"Treg Cell Therapy: How Cell Heterogeneity can Make the Difference","volume":"51","author":"Giganti","year":"2021","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.04.009","article-title":"Control of Regulatory T Cell Lineage Commitment and Maintenance","volume":"30","author":"Josefowicz","year":"2009","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-Dose Interleukin-2 Selectively Corrects Regulatory T Cell Defects in Patients With Systemic Lupus Erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) Cells in Cancer: Can Treg Cells be a New Therapeutic Target","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2174\/1573397116666200116095734","article-title":"Characterization of the Clinical and Laboratory Features of Primary and Secondary Antiphospholipid Syndrome in a Cohort of Egyptian Patients","volume":"16","author":"El-Moniem","year":"2020","journal-title":"Curr Rheumatol Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319887229","article-title":"Hemoptysis and a Cardiac Murmur: Is It Primary or Secondary Antiphospholipid Syndrome","volume":"28","author":"Kolitz","year":"2019","journal-title":"Lupus"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/rhu.0000000000001358","article-title":"Diffuse Alveolar Hemorrhage in Primary Versus Secondary Antiphospholipid Syndrome","volume":"27","author":"Sangli","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/art.40901","article-title":"The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13763","article-title":"Thrombotic Risk Stratification by Platelet Count in Patients With Antiphospholipid Antibodies: A Longitudinal Study","volume":"15","author":"Hisada","year":"2017","journal-title":"J Thromb Haemost"},{"key":"B51","doi-asserted-by":"publisher","first-page":"100610","DOI":"10.1016\/j.blre.2019.100610","article-title":"The Role of Beta-2-Glycoprotein I in Health and Disease Associating Structure With Function: More Than Just APS","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005407","article-title":"Specialized Regulatory T Cells Control Venous Blood Clot Resolution Through SPARC","volume":"137","author":"Shahneh","year":"2021","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2006.00434.x","article-title":"Autoantibodies and Prediction of Reproductive Failure","volume":"56","author":"Shoenfeld","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12560","article-title":"Antinuclear Autoantibodies and Pregnancy Outcome in Women With Unexplained Recurrent Miscarriage","volume":"76","author":"Ticconi","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2019.1565995","article-title":"Management of Pregnant Women With Antiphospholipid Antibodies","volume":"15","author":"Ruffatti","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319882507","article-title":"Complementemia in Pregnancies With Antiphospholipid Syndrome","volume":"28","author":"Tabacco","year":"2019","journal-title":"Lupus"},{"key":"B57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10067-020-05203-3","article-title":"Clinical Features Associated With Pregnancy Outcomes in Women With Positive Antiphospholipid Antibodies and Previous Adverse Pregnancy Outcomes: A Real-World Prospective Study","volume":"40","author":"Li","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2016.05.002","article-title":"A Gradient of Glucocorticoid Sensitivity Among Helper T Cell Cytokines","volume":"31","author":"Banuelos","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.109.872903","article-title":"Th17 and Th1 T-Cell Responses in Giant Cell Arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.006","article-title":"Prasugrel Inhibits Platelet-Enhanced Pro-Inflammatory CD4+ T Cell Responses in Humans","volume":"239","author":"Johnston","year":"2015","journal-title":"Atherosclerosis"}],"updated-by":[{"DOI":"10.3389\/fimmu.2022.971769","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.873644\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T09:46:29Z","timestamp":1655977589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.873644\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2022.873644"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.873644","relation":{"erratum":[{"id-type":"doi","id":"10.3389\/fimmu.2022.971769","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"article-number":"873644"}}